secwatch.observer — SEC 8-K summary
======================================

Issuer:     DocGo Inc. (DCGO)
CIK:        0001822359
Form:       8-K
Filed at:   2026-04-22T23:59:59+00:00
Accession:  0001822359-26-000017
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud

DocGo: Director Klasko to step down; Burdiek named independent Chair; special committee for cost reduction
--------------------------------------------------------------------------------

- Dr. Stephen Klasko will step down from the Board effective after the 2026 Annual Meeting on June 16, 2026, due to a new healthcare leadership role.
- Klasko's departure was not due to any disagreement with DocGo regarding operations, disclosures, policies, or practices.
- Michael Burdiek, an independent director, was appointed as independent Chair of the Board, effective at the same time as Klasko's departure.
- Jim Travers was appointed to the Audit and Compliance Committee and the Nominating and Corporate Governance Committee, replacing Klasko immediately prior to the effective time.
- On April 21, 2026, the Board formed a special committee (Vina Leite, Ira Smedra, Michael Burdiek) to identify corporate efficiencies and cost reduction opportunities.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1822359/000182235926000017/0001822359-26-000017-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1822359/000182235926000017/dcgo-20260417.htm
  HTML page:      https://secwatch.observer/filing/0001822359-26-000017

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer